ArticleWorld journal of hepatology2020

Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over.

Hideyuki Tamai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.